Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
My Portfolio
Beigene Ltd Ads
(NQ:
BGNE
)
362.80
USD
UNCHANGED
Streaming Delayed Price
Updated: 4:50 PM EST, Jan 20, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
362.80
Bid (Size)
362.80 (2)
Ask (Size)
363.25 (6)
Prev. Close
362.80
Today's Range
362.80 - 362.80
52wk Range
118.55 - 371.37
Shares Outstanding
53,760,296
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
China National Medical Products Administration Approves Tislelizumab in Combination with Chemotherapy in First-Line Advanced Squamous Non-Small Cell Lung Cancer
January 13, 2021
BeiGene's anti-PD-1 antibody received approval in China in first-line advanced squamous non-small cell lung cancer.
From
Business Wire News Releases
First Week of March 19th Options Trading For BeiGene (BGNE)
January 19, 2021
Investors in BeiGene Ltd (BGNE) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BGNE options chain...
Tags
Stocks
From
Market News Video
Performance
YTD
+39.00%
+39.00%
1 Month
+38.78%
+38.78%
3 Month
+19.91%
+19.91%
6 Month
+53.79%
+53.79%
1 Year
+113.83%
+113.83%
More News
Read More
BeiGene Announces Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab
January 11, 2021
From
Business Wire News Releases
Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid Tumor Immuno-Oncology Therapeutics Based on Strand’s Next-Generation, Multi-Functional mRNA Technology
January 11, 2021
From
Business Wire News Releases
BeiGene to Present at the J.P. Morgan 39th Annual Healthcare Conference
January 07, 2021
From
Business Wire News Releases
Week In Review: BeiGene Signs $2.2 Billion Deal With Novartis For PD-1
January 16, 2021
Tags
Stocks / Equities
Pharma/Biotech
Healthcare
From
Blogs - TalkMarkets
Why BeiGene, T2 Biosystems And Amneal Are Are Moving Today
January 12, 2021
Tags
Movers
TTOO
Trading Ideas
From
Benzinga
Beigene Stock Breaks Out To Record High On Cancer Drug OK In China
January 14, 2021
From
Investor's Business Daily
Stocks Showing Improved Relative Strength: Beigene
January 14, 2021
From
Investor's Business Daily
Beigene Surges Closer To Breakout On $2.2 Billion Deal With Novartis
January 12, 2021
From
Investor's Business Daily
Movements In Stocks After Georgia Votes
January 06, 2021
Tags
Technology
Stocks / Equities
Financial
From
Blogs - TalkMarkets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.